Compare Cart
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Cover Image
Market Research Report
Product code 
1047113

Oncology Market Size By Cancer Diagnostics & Treatment, By Cancer Type, By End-use, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
Published: | Global Market Insights Inc. | 245 Pages | Delivery time: 2-3 business days

Price

Back to Top
Oncology Market Size By Cancer Diagnostics & Treatment, By Cancer Type, By End-use, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
Published: January 7, 2022
Global Market Insights Inc.
Content info: 245 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The oncology market is anticipated to witness robust growth by 2028 owing to rising incidences of cancer across the globe. In addition, soaring liquor and tobacco consumption, coupled with surging emphasis on drug development, is slated to further bolster market growth over the forecast period.

Significant development in medical imaging technology have enabled interventional oncologists to incorporate image-guided treatments into clinical practice, allowing for targeted cancer treatment. Interventional oncology is promoting more concentrated treatments via locoregional delivery directly to the tumor, sparing as much healthy tissue as possible, particularly in organ tumors and cancers where systemic treatments are less effective, which has been favorable for oncology market outlook.

Recently, industry players have been adopting profitable strategies to gain a competitive edge in the sector, thereby enhancing market dynamics. For instance, on November 2021, GE Healthcare, a key firm in the space, performed an early investigation and demonstrated that artificial intelligence (AI) and robotics have the potential to improve precision for out-of-plane needle placement while also lowering overall procedure time.

Notably, the COVID-19 pandemic severely impacted every element of cancer care and research, with numerous countries around the world classifying screening and oncology care services as low-priority services, thereby hindering market growth. However, with widespread immunization drives and growing focus on accelerating economic growth, the industry is regaining its pre-COVID momentum.

The oncology market has further been segmented into cancer diagnostics & treatment, cancer type, end-use, and region. The cancer diagnostics & treatment segment has been divided into cancer diagnostics and cancer treatment. The cancer treatment sub-segment is anticipated to be valued at over USD 301.6 billion by the end of 2028.

Based on cancer type, the market has been categorized into lung cancer, liver cancer, prostate cancer, esophageal cancer, gastric cancer, colon & rectal cancer, breast cancer, and others. In 2021, the colon & rectal cancer sub-segment generated above USD 23.0 billion in revenue and is slated to attain a considerable market share by 2028.

In terms of end-use, the oncology market has been bifurcated into hospitals, specialty clinics, diagnostic laboratories, diagnostic imaging centers, academia, and others. In 2021, the specialty clinics sub-segment held around 5.1% market share and is estimated to grow significantly by 2028

From the regional point of view, in 2021, Latin America accounted for about 6.2% of the oncology market in terms of revenue and is likely to grow significantly by 2028. Meanwhile, the Middle East & Africa market is speculated to record sizable expansion at a CAGR of nearly 11.5% through the analysis period. Pharmaceutical companies have been making considerable investment towards the field of oncology in MEA, which is projected to propel regional market growth.

Product Code: 4879

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data Sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Global oncology industry 360 degree synopsis, 2017-2028
    • 2.1.1 Business trends
    • 2.1.2 Cancer diagnostics and treatment trends
    • 2.1.3 Cancer type trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Global Oncology Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017-2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising incidence of cancer globally
      • 3.3.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness
      • 3.3.1.3 Growing number of diagnostic laboratories in developing countries
      • 3.3.1.4 Technological advancements in developed countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High capital investment coupled with high cost associated with diagnostic imaging system
      • 3.3.2.2 High risk of side effects associated with cancer treatment
      • 3.3.2.3 Risk related with high radiation exposure affecting use of CT scanners
  • 3.4 Growth potential analysis
    • 3.4.1 By cancer diagnostics & treatment
    • 3.4.2 By cancer type
    • 3.4.3 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Company matrix analysis
  • 3.8 PESTEL analysis

Chapter 4 Global Oncology Market, By Cancer Diagnostics & Treatment

  • 4.1 Key segment trends
  • 4.2 Cancer diagnostics
    • 4.2.1 Market size, by region, 2017-2028 (USD Million)
    • 4.2.2 Tumor biomarker tests
      • 4.2.2.1 Market size, by region, 2017-2028 (USD Million)
    • 4.2.3 Imaging
      • 4.2.3.1 Market size, by region, 2017-2028 (USD Million)
    • 4.2.4 Biopsy
      • 4.2.4.1 Market size, by region, 2017-2028 (USD Million)
    • 4.2.5 Liquid biopsy
      • 4.2.5.1 Market size, by region, 2017-2028 (USD Million)
    • 4.2.6 Immunohistochemistry
      • 4.2.6.1 Market size, by region, 2017-2028 (USD Million)
    • 4.2.7 In Situ Hybridization
      • 4.2.7.1 Market size, by region, 2017-2028 (USD Million)
  • 4.3 Cancer treatment
    • 4.3.1 Market size, by region, 2017-2028 (USD Million)
    • 4.3.2 Chemotherapy
      • 4.3.2.1 Market size, by region, 2017-2028 (USD Million)
    • 4.3.3 Targeted therapy
      • 4.3.3.1 Market size, by region, 2017-2028 (USD Million)
    • 4.3.4 Immunotherapy
      • 4.3.4.1 Market size, by region, 2017-2028 (USD Million)
    • 4.3.5 Hormonal therapy
      • 4.3.5.1 Market size, by region, 2017-2028 (USD Million)
    • 4.3.6 Others
      • 4.3.6.1 Market size, by region, 2017-2028 (USD Million)

Chapter 5 Global Oncology Market, By Cancer Type

  • 5.1 Key segment trends
  • 5.2 Lung cancer
    • 5.2.1 Market size, by region, 2017-2028 (USD Million)
  • 5.3 Prostate cancer
    • 5.3.1 Market size, by region, 2017-2028 (USD Million)
  • 5.4 Colon & rectal cancer
    • 5.4.1 Market size, by region, 2017-2028 (USD Million)
  • 5.5 Gastric cancer
    • 5.5.1 Market size, by region, 2017-2028 (USD Million)
  • 5.6 Esophageal cancer
    • 5.6.1 Market size, by region, 2017-2028 (USD Million)
  • 5.7 Liver cancer
    • 5.7.1 Market size, by region, 2017-2028 (USD Million)
  • 5.8 Breast cancer
    • 5.8.1 Market size, by region, 2017-2028 (USD Million)
  • 5.9 Others
    • 5.9.1 Market size, by region, 2017-2028 (USD Million)

Chapter 6 Global Oncology Market, By End-use

  • 6.1 Key segment trend
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2017-2028 (USD Million)
  • 6.3 Diagnostic laboratories
    • 6.3.1 Market size, by region, 2017-2028 (USD Million)
  • 6.4 Diagnostic imaging centers
    • 6.4.1 Market size, by region, 2017-2028 (USD Million)
  • 6.5 Academia
    • 6.5.1 Market size, by region, 2017-2028 (USD Million)
  • 6.6 Specialty clinics
    • 6.6.1 Market size, by region, 2017-2028 (USD Million)
  • 6.7 Others
    • 6.7.1 Market size, by region, 2017-2028 (USD Million)

Chapter 7 Global Oncology Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017-2028 (USD Million)
    • 7.2.2 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
      • 7.2.2.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
      • 7.2.2.2 Market size, by cancer treatment, 2017-2028 (USD Million)
    • 7.2.3 Market size, by cancer type, 2017-2028 (USD Million)
    • 7.2.4 Market size, by end-use, 2017-2028 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.2.5.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.2.5.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.2.5.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.2.6.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.2.6.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.2.6.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017-2028 (USD Million)
    • 7.3.2 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
      • 7.3.2.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
      • 7.3.2.2 Market size, by cancer treatment, 2017-2028 (USD Million)
    • 7.3.3 Market size, by cancer type, 2017-2028 (USD Million)
    • 7.3.4 Market size, by end-use, 2017-2028 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.3.5.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
      • 7.3.5.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.3.5.3 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.3.5.4 Market size, by end-use, 2017-2028 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.3.6.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.3.6.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.3.6.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.3.7.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.3.7.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.3.7.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.3.8 Spain
      • 7.3.8.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.3.8.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.3.8.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.3.8.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.3.9 Italy
      • 7.3.9.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.3.9.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.3.9.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.3.9.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017-2028 (USD Million)
    • 7.4.2 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
      • 7.4.2.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
      • 7.4.2.2 Market size, by cancer treatment, 2017-2028 (USD Million)
    • 7.4.3 Market size, by cancer type, 2017-2028 (USD Million)
    • 7.4.4 Market size, by end-use, 2017-2028 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.4.5.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.4.5.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.4.5.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.4.6.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.4.6.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.4.6.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.4.7.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.4.7.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.4.7.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.4.8.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.4.8.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.4.8.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017-2028 (USD Million)
    • 7.5.2 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
      • 7.5.2.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
      • 7.5.2.2 Market size, by cancer treatment, 2017-2028 (USD Million)
    • 7.5.3 Market size, by cancer type, 2017-2028 (USD Million)
    • 7.5.4 Market size, by end-use, 2017-2028 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.5.5.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.5.5.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.5.5.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.5.6.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.5.6.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.5.6.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.6 Middle East and Africa
    • 7.6.1 Market size, by country, 2017-2028 (USD Million)
    • 7.6.2 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
      • 7.6.2.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
      • 7.6.2.2 Market size, by cancer treatment, 2017-2028 (USD Million)
    • 7.6.3 Market size, by cancer type, 2017-2028 (USD Million)
    • 7.6.4 Market size, by end-use, 2017-2028 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.6.5.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.6.5.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.6.5.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2017-2028 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by cancer diagnostics & treatment, 2017-2028 (USD Million)
        • 7.6.6.1.1 Market size, by cancer diagnostics, 2017-2028 (USD Million)
        • 7.6.6.1.2 Market size, by cancer treatment, 2017-2028 (USD Million)
      • 7.6.6.2 Market size, by cancer type, 2017-2028 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2017-2028 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2021
  • 8.2 Abbott
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Bayer AG
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Biocartis
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 BioMerieux SA
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Bio-Rad Laboratories Inc
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Cancer Genetics
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 GE Healthcare
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Kite Pharma (Gilead Science, Inc)
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Janssen Diagnostics, LLC (Johnson & Johnson)
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 F. Hoffmann-La Roche Ltd
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Siemens Healthineers
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Sysmex Corporation
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Thermo-Fischer Scientific
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
  • 8.15 Tesaro Inc (GlaxoSmithKline Plc)
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Product landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 SWOT analysis
  • 8.16 Amgen Inc
    • 8.16.1 Business overview
    • 8.16.2 Financial data
    • 8.16.3 Product landscape
    • 8.16.4 Strategic outlook
    • 8.16.5 SWOT analysis
  • 8.17 AstraZeneca
    • 8.17.1 Business overview
    • 8.17.2 Financial data
    • 8.17.3 Product landscape
    • 8.17.4 Strategic outlook
    • 8.17.5 SWOT analysis
  • 8.18 Merck & Co., Inc
    • 8.18.1 Business overview
    • 8.18.2 Financial data
    • 8.18.3 Product landscape
    • 8.18.4 Strategic outlook
    • 8.18.5 SWOT analysis
  • 8.19 Pfizer, Inc
    • 8.19.1 Business overview
    • 8.19.2 Financial data
    • 8.19.3 Product landscape
    • 8.19.4 Strategic outlook
    • 8.19.5 SWOT analysis
  • 8.20 ZIOPHARM Oncology, Inc
    • 8.20.1 Business overview
    • 8.20.2 Financial data
    • 8.20.3 Product landscape
    • 8.20.4 Strategic outlook
    • 8.20.5 SWOT analysis

Data Tables

  • TABLE 1 Global oncology market, 2017-2021 (USD Million)
  • TABLE 2 Global oncology market, 2022-2028 (USD Million)
  • TABLE 3 Global oncology market, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 4 Global oncology market, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 5 Global oncology market, by cancer type, 2017-2021 (USD Million)
  • TABLE 6 Global oncology market, by cancer type, 2022-2028 (USD Million)
  • TABLE 7 Global oncology market, by end-use, 2017-2021 (USD Million)
  • TABLE 8 Global oncology market, by end-use, 2022-2028 (USD Million)
  • TABLE 9 Global oncology market, by region, 2017-2021 (USD Million)
  • TABLE 10 Global oncology market, by region, 2022-2028 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Cancer diagnostics market size, by region, 2017-2021 (USD Million)
  • TABLE 13 Cancer diagnostics market size, by region, 2022-2028 (USD Million)
  • TABLE 14 Tumor biomarkers tests market size, by region, 2017-2021 (USD Million)
  • TABLE 15 Tumor biomarkers tests market size, by region, 2022-2028 (USD Million)
  • TABLE 16 Imaging market size, by region, 2017-2021 (USD Million)
  • TABLE 17 Imaging market size, by region, 2022-2028 (USD Million)
  • TABLE 18 Biopsy market size, by region, 2017-2021 (USD Million)
  • TABLE 19 Biopsy market size, by region, 2022-2028 (USD Million)
  • TABLE 20 Liquid biopsy market size, by region, 2017-2021 (USD Million)
  • TABLE 21 Liquid biopsy market size, by region, 2022-2028 (USD Million)
  • TABLE 22 Immunohistochemistry market size, by region, 2017-2021 (USD Million)
  • TABLE 23 Immunohistochemistry market size, by region, 2022-2028 (USD Million)
  • TABLE 24 In situ hybridization market size, by region, 2017-2021 (USD Million)
  • TABLE 25 In situ hybridization market size, by region, 2022-2028 (USD Million)
  • TABLE 26 Cancer treatment market size, by region, 2017-2021 (USD Million)
  • TABLE 27 Cancer treatment market size, by region, 2022-2028 (USD Million)
  • TABLE 28 Chemotherapy market size, by region, 2017-2021 (USD Million)
  • TABLE 29 Chemotherapy market size, by region, 2022-2028 (USD Million)
  • TABLE 30 Targeted therapy market size, by region, 2017-2021 (USD Million)
  • TABLE 31 Targeted therapy market size, by region, 2022-2028 (USD Million)
  • TABLE 32 Immunotherapy market size, by region, 2017-2021 (USD Million)
  • TABLE 33 Immunotherapy market size, by region, 2022-2028 (USD Million)
  • TABLE 34 Hormonal therapy market size, by region, 2017-2021 (USD Million)
  • TABLE 35 Hormonal therapy market size, by region, 2022-2028 (USD Million)
  • TABLE 36 Others market size, by region, 2017-2021 (USD Million)
  • TABLE 37 Others market size, by region, 2022-2028 (USD Million)
  • TABLE 38 Lung cancer market size, by region, 2017-2021 (USD Million)
  • TABLE 39 Lung cancer market size, by region, 2022-2028 (USD Million)
  • TABLE 40 Prostate cancer market size, by region, 2017-2021 (USD Million)
  • TABLE 41 Prostate cancer market size, by region, 2022-2028 (USD Million)
  • TABLE 42 Colon and rectal cancer market size, by region, 2017-2021 (USD Million)
  • TABLE 43 Colon and rectal cancer market size, by region, 2022-2028 (USD Million)
  • TABLE 44 Gastric cancer market size, by region, 2017-2021 (USD Million)
  • TABLE 45 Gastric cancer market size, by region, 2022-2028 (USD Million)
  • TABLE 46 Esophageal cancer market size, by region, 2017-2021 (USD Million)
  • TABLE 47 Esophageal cancer market size, by region, 2022-2028 (USD Million)
  • TABLE 48 Liver market size, by region, 2017-2021 (USD Million)
  • TABLE 49 Liver market size, by region, 2022-2028 (USD Million)
  • TABLE 50 Breast cancer market size, by region, 2017-2021 (USD Million)
  • TABLE 51 Breast cancer market size, by region, 2022-2028 (USD Million)
  • TABLE 52 Others market size, by region, 2017-2021 (USD Million)
  • TABLE 53 Others market size, by region, 2022-2028 (USD Million)
  • TABLE 54 Hospitals market size, by region, 2017-2021 (USD Million)
  • TABLE 55 Hospitals market size, by region, 2022-2028 (USD Million)
  • TABLE 56 Diagnostic laboratories market size, by region, 2017-2021 (USD Million)
  • TABLE 57 Diagnostic laboratories market size, by region, 2022-2028 (USD Million)
  • TABLE 58 Diagnostic imaging centers market size, by region, 2017-2021 (USD Million)
  • TABLE 59 Diagnostic imaging centers market size, by region, 2022-2028 (USD Million)
  • TABLE 60 Academia market size, by region, 2017-2021 (USD Million)
  • TABLE 61 Academia market size, by region, 2022-2028 (USD Million)
  • TABLE 62 Specialty clinics market size, by region, 2017-2021 (USD Million)
  • TABLE 63 Specialty clinics market size, by region, 2022-2028 (USD Million)
  • TABLE 64 Others market size, by region, 2017-2021 (USD Million)
  • TABLE 65 Others market size, by region, 2022-2028 (USD Million)
  • TABLE 66 North America oncology market size, by country, 2017-2021 (USD Million)
  • TABLE 67 North America oncology market size, by country, 2022-2028 (USD Million)
  • TABLE 68 North America oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 69 North America oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 70 North America oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 71 North America oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 72 North America oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 73 North America oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 74 North America oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 75 North America oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 76 North America oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 77 North America oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 78 U.S. oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 79 U.S. oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 80 U.S. oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 81 U.S. oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 82 U.S. oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 83 U.S. oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 84 U.S. oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 85 U.S. oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 86 U.S. oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 87 U.S. oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 88 Canada oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 89 Canada oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 90 Canada oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 91 Canada oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 92 Canada oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 93 Canada oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 94 Canada oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 95 Canada oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 96 Canada oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 97 Canada oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 98 Europe oncology market size, by country, 2017-2021 (USD Million)
  • TABLE 99 Europe oncology market size, by country, 2022-2028 (USD Million)
  • TABLE 100 Europe oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 101 Europe oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 102 Europe oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 103 Europe oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 104 Europe oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 105 Europe oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 106 Europe oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 107 Europe oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 108 Europe oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 109 Europe oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 110 Germany oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 111 Germany oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 112 Germany oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 113 Germany oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 114 Germany oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 115 Germany oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 116 Germany oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 117 Germany oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 118 Germany oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 119 Germany oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 120 UK oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 121 UK oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 122 UK oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 123 UK oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 124 UK oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 125 UK oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 126 UK oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 127 UK oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 128 UK oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 129 UK oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 130 France oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 131 France oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 132 France oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 133 France oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 134 France oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 135 France oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 136 France oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 137 France oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 138 France oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 139 France oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 140 Spain oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 141 Spain oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 142 Spain oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 143 Spain oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 144 Spain oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 145 Spain oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 146 Spain oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 147 Spain oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 148 Spain oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 149 Spain oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 150 Italy oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 151 Italy oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 152 Italy oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 153 Italy oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 154 Italy oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 155 Italy oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 156 Italy oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 157 Italy oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 158 Italy oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 159 Italy oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 160 Asia Pacific oncology market size, by country, 2017-2021 (USD Million)
  • TABLE 161 Europe oncology market size, by country, 2022-2028 (USD Million)
  • TABLE 162 Asia Pacific oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 163 Asia Pacific oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 164 Asia Pacific oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 165 Asia Pacific oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 166 Asia Pacific oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 167 Asia Pacific oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 168 Asia Pacific oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 169 Asia Pacific oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 170 Asia Pacific oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 171 Asia Pacific oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 172 China oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 173 China oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 174 China oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 175 China oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 176 China oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 177 China oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 178 China oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 179 China oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 180 China oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 181 China market size, by end-use, 2022-2028 (USD Million)
  • TABLE 182 India oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 183 India oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 184 India oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 185 India oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 186 India oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 187 India oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 188 India oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 189 India oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 190 India oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 191 India oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 192 Japan oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 193 Japan oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 194 Japan oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 195 Japan oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 196 Japan oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 197 Japan oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 198 Japan oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 199 Japan oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 200 Japan oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 201 Japan oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 202 Australia oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 203 Australia oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 204 Australia oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 205 Australia oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 206 Australia oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 207 Australia oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 208 Australia oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 209 Australia oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 210 Australia oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 211 Australia oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 212 Latin America oncology market size, by country, 2017-2021 (USD Million)
  • TABLE 213 Latin America oncology market size, by country, 2022-2028 (USD Million)
  • TABLE 214 Latin America oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 215 Latin America oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 216 Latin America oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 217 Latin America oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 218 Latin America oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 219 Latin America oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 220 Latin America oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 221 Latin America oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 222 Latin America oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 223 Latin America oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 224 Brazil oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 225 Brazil oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 226 Brazil oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 227 Brazil oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 228 Brazil oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 229 Brazil oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 230 Brazil oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 231 Brazil oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 232 Brazil oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 233 Brazil market size, by end-use, 2022-2028 (USD Million)
  • TABLE 234 Mexico oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 235 Mexico oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 236 Mexico oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 237 Mexico oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 238 Mexico oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 239 Mexico oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 240 Mexico oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 241 Mexico oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 242 Mexico oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 243 Mexico oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 244 MEA oncology market size, by country, 2017-2021 (USD Million)
  • TABLE 245 MEA oncology market size, by country, 2022-2028 (USD Million)
  • TABLE 246 MEA oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 247 MEA oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 248 MEA oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 249 MEA oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 250 MEA oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 251 MEA oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 252 MEA oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 253 MEA oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 254 MEA oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 255 MEA oncology market size, by end-use, 2022-2028 (USD Million)
  • TABLE 256 South Africa oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 257 South Africa oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 258 South Africa oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 259 South Africa oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 260 South Africa oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 261 South Africa oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 262 South Africa oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 263 South Africa oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 264 South Africa oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 265 South Africa market size, by end-use, 2022-2028 (USD Million)
  • TABLE 266 Saudi Arabia oncology market size, by cancer diagnostics & treatment, 2017-2021 (USD Million)
  • TABLE 267 Saudi Arabia oncology market size, by cancer diagnostics & treatment, 2022-2028 (USD Million)
  • TABLE 268 Saudi Arabia oncology market size, by cancer diagnostics, 2017-2021 (USD Million)
  • TABLE 269 Saudi Arabia oncology market size, by cancer diagnostics, 2022-2028 (USD Million)
  • TABLE 270 Saudi Arabia oncology market size, by cancer treatment, 2017-2021 (USD Million)
  • TABLE 271 Saudi Arabia oncology market size, by cancer treatment, 2022-2028 (USD Million)
  • TABLE 272 Saudi Arabia oncology market size, by cancer type, 2017-2021 (USD Million)
  • TABLE 273 Saudi Arabia oncology market size, by cancer type, 2022-2028 (USD Million)
  • TABLE 274 Saudi Arabia oncology market size, by end-use, 2017-2021 (USD Million)
  • TABLE 275 Saudi Arabia oncology market size, by end-use, 2022-2028 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach-cancer diagnostics segment
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Global oncology industry 360 degree synopsis, 2017 - 2028
  • FIG. 4 Industry segmentation
  • FIG. 5 Global oncology market, 2017 - 2028 (USD Mn)
  • FIG. 6 Growth potential analysis, by cancer diagnostics & treatment
  • FIG. 7 Growth potential analysis, by cancer type
  • FIG. 8 Growth potential analysis, by end-use
  • FIG. 9 Porter's analysis
  • FIG. 10 Company matrix analysis, 2021
  • FIG. 11 PESTEL analysis
  • FIG. 12 Key segment trends, by cancer diagnostics & treatment
  • FIG. 13 Key segment trends, by cancer type
  • FIG. 14 Key segment trends, by end-use
  • FIG. 15 Key regional trends
  • FIG. 16 Competitive dashboard